Accurate, Focused Research on Law, Technology and Knowledge Discovery Since 2002

FDA list of drugmakers the agency says are using “gaming” tactics to keep generic competition off the market

Business Insider: “The FDA just published a list of drug makers the agency says are using “gaming” tactics to keep generic competition off the market. The list of 52 drugs are made by some of the biggest pharmaceutical companies including Novartis, Pfizer, Mylan, and Valeant “FDA is committed – among other things – to addressing and improving transparency about this and other gaming tactics that delay the generic competition Congress intended,” the agency said on Thursday. [h/t Pete Weiss]

Sorry, comments are closed for this post.